DiaSorin S.p.A. (OTCMKTS:DSRLF – Get Free Report) was the target of a significant growth in short interest during the month of January. As of January 15th, there was short interest totalling 54,100 shares, a growth of 14.6% from the December 31st total of 47,200 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is presently 541.0 days.
DiaSorin Stock Performance
DSRLF opened at $102.64 on Monday. The firm’s fifty day moving average is $106.46 and its two-hundred day moving average is $103.03. DiaSorin has a twelve month low of $102.64 and a twelve month high of $108.79.
Analyst Upgrades and Downgrades
Separately, UBS Group lowered shares of DiaSorin from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 26th.
DiaSorin Company Profile
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.
See Also
- Five stocks we like better than DiaSorin
- The How And Why of Investing in Oil Stocks
- 3 Stocks to Gain From Trump’s Return-to-Office Mandate
- How to Buy Cheap Stocks Step by Step
- Crane Stock Soars, But the Best Could Be Yet to Come: Here’s Why
- How to Use the MarketBeat Dividend Calculator
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
Receive News & Ratings for DiaSorin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaSorin and related companies with MarketBeat.com's FREE daily email newsletter.